Breast Reduction Epidemiology and Complications in Nonbinary, Transgender, and Cisgender Adults (Q30162): Difference between revisions

From lgbtDB
Jump to navigation Jump to search
(‎Created a new Item)
 
(‎Added [en] label: Breast Reduction Epidemiology and Complications in Nonbinary, Transgender, and Cisgender Adults)
 
label / enlabel / en
 
Breast Reduction Epidemiology and Complications in Nonbinary, Transgender, and Cisgender Adults

Latest revision as of 22:50, 8 November 2024

No description defined
  • Breast Reduction Epidemiology and Complications in Nonbinary, Transgender, and Cisgender Adults.
Language Label Description Also known as
English
Breast Reduction Epidemiology and Complications in Nonbinary, Transgender, and Cisgender Adults
No description defined
  • Breast Reduction Epidemiology and Complications in Nonbinary, Transgender, and Cisgender Adults.

Statements

title
Breast Reduction Epidemiology and Complications in Nonbinary, Transgender, and Cisgender Adults. (English)
1 reference
stated in
PubMed
abstract
Research in gender-affirming chest surgery has primarily compared cisgender versus transgender and gender-diverse (TGD) people, without specifically addressing nonbinary people. (English)
source label
INTRODUCTION (English)
subsection NLM category
background section
series ordinal
1
copyright statement
Copyright © 2024. Published by Elsevier Inc. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
Elsevier
1 reference
stated in
PubMed
This study will assess surgical complications between cisgender, transgender, and nonbinary adults undergoing breast reductions. (English)
source label
INTRODUCTION (English)
subsection NLM category
background section
series ordinal
2
copyright statement
Copyright © 2024. Published by Elsevier Inc. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
Elsevier
1 reference
stated in
PubMed
The National Surgical Quality Improvement Program databases from 2015 to 2021 were used to identify TGD patients who underwent breast reduction (Current Procedural Terminology code: 19318) and cisgender patients who underwent this procedure for cosmesis or cancer prophylaxis. (English)
source label
METHODS (English)
subsection NLM category
methods section
series ordinal
3
copyright statement
Copyright © 2024. Published by Elsevier Inc. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
Elsevier
1 reference
stated in
PubMed
Analysis of variance tests, chi-squared tests, unpaired t-tests, and regression models compared complications among cisgender, transgender, and nonbinary patients. (English)
source label
METHODS (English)
subsection NLM category
methods section
series ordinal
4
copyright statement
Copyright © 2024. Published by Elsevier Inc. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
Elsevier
1 reference
stated in
PubMed
A total of 1222 patients met the inclusion criteria: 380 (31.1%) were cisgender, 769 (62.9%) were transgender, and 73 (6.0%) were nonbinary. (English)
source label
RESULTS (English)
subsection NLM category
results section
series ordinal
5
copyright statement
Copyright © 2024. Published by Elsevier Inc. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
Elsevier
1 reference
stated in
PubMed
The proportion of TGD patients grew significantly relative to cisgender patients over the study period (P < 0.001). (English)
source label
RESULTS (English)
subsection NLM category
results section
series ordinal
6
copyright statement
Copyright © 2024. Published by Elsevier Inc. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
Elsevier
1 reference
stated in
PubMed
The overall all-cause complication rate was 3.4%, with 4.2% of cisgender, 1.4% of nonbinary, and 3.1% of transgender patients experiencing surgical complications. (English)
source label
RESULTS (English)
subsection NLM category
results section
series ordinal
7
copyright statement
Copyright © 2024. Published by Elsevier Inc. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
Elsevier
1 reference
stated in
PubMed
After adjusting for confounding variables, no statistically significant difference was observed in all-cause complication rates between the cohorts. (English)
source label
RESULTS (English)
subsection NLM category
results section
series ordinal
8
copyright statement
Copyright © 2024. Published by Elsevier Inc. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
Elsevier
1 reference
stated in
PubMed
In the sample, 19 transgender patients (2.5%) underwent reoperation. (English)
source label
RESULTS (English)
subsection NLM category
results section
series ordinal
9
copyright statement
Copyright © 2024. Published by Elsevier Inc. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
Elsevier
1 reference
stated in
PubMed
Transgender patients had a lower likelihood of wound complications (odds ratio: 0.172; 95% confidence interval: 0.035-0.849; P = 0.031) compared to cisgender patients and nonbinary patients. (English)
source label
RESULTS (English)
subsection NLM category
results section
series ordinal
10
copyright statement
Copyright © 2024. Published by Elsevier Inc. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
Elsevier
1 reference
stated in
PubMed
None of the patients experienced a severe systemic complication. (English)
source label
RESULTS (English)
subsection NLM category
results section
series ordinal
11
copyright statement
Copyright © 2024. Published by Elsevier Inc. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
Elsevier
1 reference
stated in
PubMed
The findings emphasize the growing demand and safety of gender-affirming breast reductions. (English)
source label
CONCLUSIONS (English)
subsection NLM category
conclusion section
series ordinal
12
copyright statement
Copyright © 2024. Published by Elsevier Inc. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
Elsevier
1 reference
stated in
PubMed
They underscore the importance of continued research and tailored approaches to delivering care to nonbinary and transgender patients, addressing their diverse needs and improving access to gender-affirming surgeries. (English)
source label
CONCLUSIONS (English)
subsection NLM category
conclusion section
series ordinal
13
copyright statement
Copyright © 2024. Published by Elsevier Inc. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
Elsevier
1 reference
stated in
PubMed
date published
October 2024
1 reference
stated in
PubMed
date issued
October 2024
1 reference
stated in
PubMed
author
volume
302
1 reference
stated in
PubMed
page(s)
437-445
1 reference
stated in
PubMed
page start
437
1 reference
stated in
PubMed
page end
445
1 reference
stated in
PubMed
publisher item identifier
S0022-4804(24)00467-0
1 reference
stated in
PubMed
 
Retrieved from "https://lgbtdb.wikibase.cloud/w/index.php?title=Item:Q30162&oldid=183497"